Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 8—August 2020
Research

Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States

Manish PatelComments to Author , Jufu Chen, Sara Kim, Shikha Garg, Brendan Flannery, Zaid Haddadin, Danielle Rankin, Natasha Halasa, H. Keipp Talbot, and Carrie Reed
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Patel, J. Chen, S. Kim, S. Garg, B. Flannery, C. Reed); Vanderbilt University, Nashville, Tennessee, USA (Z. Haddadin, D. Rankin, N. Halasa, H. Keipp Talbot)

Main Article

Figure 1

Algorithm for case definitions of immunosuppressive conditions in MarketScan claims database of Commercial and Medicare enrollees, United States, August 2012–July 2017. *These 3 conditions were deemed to be immunosuppressive. †These 3 conditions were deemed to be immunosuppressive only if enrollees were given chemotherapeutic agents or immune-modulating agents or if enrollees who had rheumatologic or inflammatory conditions were receiving systemic corticosteroids. ‡We deemed that enrollees might

Figure 1. Algorithm for case definitions of immunosuppressive conditions in MarketScan claims database of Commercial and Medicare enrollees, United States, August 2012–July 2017. *These 3 conditions were deemed to be immunosuppressive. †These 3 conditions were deemed to be immunosuppressive only if enrollees were given chemotherapeutic agents or immune-modulating agents or if enrollees who had rheumatologic or inflammatory conditions were receiving systemic corticosteroids. ‡We deemed that enrollees might be given chemotherapeutic agents or immune-modulating agents and not be captured by ICD codes (from the 9th Revision, Clinical Modification, or 10th Revision, Clinical Modification) for the 6 potential immunosuppressive conditions described in the first 2 footnotes. We excluded treatment with corticosteroids for <14 days from these groups to avoid capturing enrollees who might be receiving short-term bursts of corticosteroids (e.g., those with asthma). ICD, International Classification of Diseases.

Main Article

Page created: April 29, 2020
Page updated: July 17, 2020
Page reviewed: July 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external